The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma.
 
Thejus Jayakrishnan
No Relationships to Disclose
 
Naseer Sangwan
No Relationships to Disclose
 
Kanika G. Nair
No Relationships to Disclose
 
Suneel Deepak Kamath
Consulting or Advisory Role - Exelixis; Foundation Medicine; Guardant Health; Seagen; Tempus
Speakers' Bureau - AstraZeneca; AstraZeneca; Merck; Pfizer; Takeda
 
Mehrie Patel
No Relationships to Disclose
 
Daniel Joyce
No Relationships to Disclose
 
Matthew Walsh
No Relationships to Disclose
 
Robert Simon
No Relationships to Disclose
 
Deepak Vadehra
No Relationships to Disclose
 
Renuka V. Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bayer; Eisai; Exelixis; Incyte; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sandoz; Sun pharma; Tersera
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - AstraZeneca; Genentech; Replimune
 
Christos Fountzilas
Research Funding - Amgen (Inst); Aravive (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals (Inst); Biomea Fusion (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Corcept Therapeutics (Inst); CrystalGenomics (Inst); Dragonfly Therapeutics (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Kadmon (Inst); Legend Biotech USA Inc (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Sanofi (Inst); Seagen (Inst); Taiho Oncology (Inst); TransThera Biosciences (Inst); Valar Labs (Inst)
Travel, Accommodations, Expenses - CG Pharmaceuticals
 
Alok A. Khorana
Honoraria - Anthos Therapeutics; Bayer; BMS; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Anthos Therapeutics; Bayer; BMS; Janssen; Pfizer; Sanofi
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Leap Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen